Financhill
Buy
57

OWLT Quote, Financials, Valuation and Earnings

Last price:
$7.25
Seasonality move :
-18.61%
Day range:
$6.50 - $7.08
52-week range:
$2.75 - $7.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.03x
P/B ratio:
--
Volume:
156.7K
Avg. volume:
71.6K
1-year change:
50.22%
Market cap:
$114.2M
Revenue:
$78.1M
EPS (TTM):
-$1.43

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
OWLT
Owlet
$18.1M -$0.24 7.17% -40% $10.83
CATX
Perspective Therapeutics
$143.9K -$0.27 -- -55.87% $14.2692
RVP
Retractable Technologies
-- -- -- -- --
VNRX
VolitionRX
$1.1M -$0.05 6.24% -40.63% $2.93
VTAK
Catheter Precision
$310K -$0.20 118.75% -11.57% --
XTNT
Xtant Medical Holdings
$31.2M -$0.01 4.73% -33.33% $1.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
OWLT
Owlet
$6.91 $10.83 $114.2M -- $0.00 0% 1.03x
CATX
Perspective Therapeutics
$3.5300 $14.2692 $262M -- $0.00 0% 24.88x
RVP
Retractable Technologies
$0.65 -- $19.6M -- $0.00 0% 0.58x
VNRX
VolitionRX
$0.72 $2.93 $73.7M -- $0.00 0% 49.29x
VTAK
Catheter Precision
$0.35 -- $3.8M 0.40x $0.00 0% 3.96x
XTNT
Xtant Medical Holdings
$0.62 $1.75 $86.7M -- $0.00 0% 0.70x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
OWLT
Owlet
732.25% 1.880 20.55% 0.81x
CATX
Perspective Therapeutics
-- -0.117 -- --
RVP
Retractable Technologies
1.48% -0.665 12.06% 4.40x
VNRX
VolitionRX
-29.91% 1.866 11.38% 0.34x
VTAK
Catheter Precision
17.75% -2.440 53.57% 0.13x
XTNT
Xtant Medical Holdings
43.24% 1.041 51.14% 0.96x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
OWLT
Owlet
$11.3M -$2.7M -- -- 19.09% -$6M
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
RVP
Retractable Technologies
-$1.9K -$3.2M -25.99% -26.39% -122.86% -$1.6M
VNRX
VolitionRX
-- -$5.4M -- -- -2183.56% -$4.3M
VTAK
Catheter Precision
$132K -$3.5M -126.5% -137.84% -3300.7% -$2.3M
XTNT
Xtant Medical Holdings
$20.2M $1.1M -15.44% -26.62% 3.28% $87K

Owlet vs. Competitors

  • Which has Higher Returns OWLT or CATX?

    Perspective Therapeutics has a net margin of 14.33% compared to Owlet's net margin of --. Owlet's return on equity of -- beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    OWLT
    Owlet
    53.67% $0.11 $1.9M
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About OWLT or CATX?

    Owlet has a consensus price target of $10.83, signalling upside risk potential of 56.78%. On the other hand Perspective Therapeutics has an analysts' consensus of $14.2692 which suggests that it could grow by 304.23%. Given that Perspective Therapeutics has higher upside potential than Owlet, analysts believe Perspective Therapeutics is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    OWLT
    Owlet
    3 0 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is OWLT or CATX More Risky?

    Owlet has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.093, suggesting its more volatile than the S&P 500 by 9.29%.

  • Which is a Better Dividend Stock OWLT or CATX?

    Owlet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owlet pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OWLT or CATX?

    Owlet quarterly revenues are $21.1M, which are larger than Perspective Therapeutics quarterly revenues of --. Owlet's net income of $3M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, Owlet's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owlet is 1.03x versus 24.88x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OWLT
    Owlet
    1.03x -- $21.1M $3M
    CATX
    Perspective Therapeutics
    24.88x -- -- -$18.2M
  • Which has Higher Returns OWLT or RVP?

    Retractable Technologies has a net margin of 14.33% compared to Owlet's net margin of -126.59%. Owlet's return on equity of -- beat Retractable Technologies's return on equity of -26.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    OWLT
    Owlet
    53.67% $0.11 $1.9M
    RVP
    Retractable Technologies
    -0.02% -$0.35 $77.8M
  • What do Analysts Say About OWLT or RVP?

    Owlet has a consensus price target of $10.83, signalling upside risk potential of 56.78%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Owlet has higher upside potential than Retractable Technologies, analysts believe Owlet is more attractive than Retractable Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    OWLT
    Owlet
    3 0 0
    RVP
    Retractable Technologies
    0 0 0
  • Is OWLT or RVP More Risky?

    Owlet has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.386, suggesting its more volatile than the S&P 500 by 38.583%.

  • Which is a Better Dividend Stock OWLT or RVP?

    Owlet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owlet pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

  • Which has Better Financial Ratios OWLT or RVP?

    Owlet quarterly revenues are $21.1M, which are larger than Retractable Technologies quarterly revenues of $8.3M. Owlet's net income of $3M is higher than Retractable Technologies's net income of -$10.5M. Notably, Owlet's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owlet is 1.03x versus 0.58x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OWLT
    Owlet
    1.03x -- $21.1M $3M
    RVP
    Retractable Technologies
    0.58x -- $8.3M -$10.5M
  • Which has Higher Returns OWLT or VNRX?

    VolitionRX has a net margin of 14.33% compared to Owlet's net margin of -2201.34%. Owlet's return on equity of -- beat VolitionRX's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    OWLT
    Owlet
    53.67% $0.11 $1.9M
    VNRX
    VolitionRX
    -- -$0.06 -$22.6M
  • What do Analysts Say About OWLT or VNRX?

    Owlet has a consensus price target of $10.83, signalling upside risk potential of 56.78%. On the other hand VolitionRX has an analysts' consensus of $2.93 which suggests that it could grow by 311.13%. Given that VolitionRX has higher upside potential than Owlet, analysts believe VolitionRX is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    OWLT
    Owlet
    3 0 0
    VNRX
    VolitionRX
    2 1 0
  • Is OWLT or VNRX More Risky?

    Owlet has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.072, suggesting its more volatile than the S&P 500 by 7.247%.

  • Which is a Better Dividend Stock OWLT or VNRX?

    Owlet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owlet pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OWLT or VNRX?

    Owlet quarterly revenues are $21.1M, which are larger than VolitionRX quarterly revenues of $246.4K. Owlet's net income of $3M is higher than VolitionRX's net income of -$5.4M. Notably, Owlet's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owlet is 1.03x versus 49.29x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OWLT
    Owlet
    1.03x -- $21.1M $3M
    VNRX
    VolitionRX
    49.29x -- $246.4K -$5.4M
  • Which has Higher Returns OWLT or VTAK?

    Catheter Precision has a net margin of 14.33% compared to Owlet's net margin of -2828.67%. Owlet's return on equity of -- beat Catheter Precision's return on equity of -137.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    OWLT
    Owlet
    53.67% $0.11 $1.9M
    VTAK
    Catheter Precision
    92.31% -$0.36 $9.6M
  • What do Analysts Say About OWLT or VTAK?

    Owlet has a consensus price target of $10.83, signalling upside risk potential of 56.78%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 479.71%. Given that Catheter Precision has higher upside potential than Owlet, analysts believe Catheter Precision is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    OWLT
    Owlet
    3 0 0
    VTAK
    Catheter Precision
    0 0 0
  • Is OWLT or VTAK More Risky?

    Owlet has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.850, suggesting its less volatile than the S&P 500 by 184.968%.

  • Which is a Better Dividend Stock OWLT or VTAK?

    Owlet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owlet pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OWLT or VTAK?

    Owlet quarterly revenues are $21.1M, which are larger than Catheter Precision quarterly revenues of $143K. Owlet's net income of $3M is higher than Catheter Precision's net income of -$4M. Notably, Owlet's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owlet is 1.03x versus 3.96x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OWLT
    Owlet
    1.03x -- $21.1M $3M
    VTAK
    Catheter Precision
    3.96x 0.40x $143K -$4M
  • Which has Higher Returns OWLT or XTNT?

    Xtant Medical Holdings has a net margin of 14.33% compared to Owlet's net margin of 0.18%. Owlet's return on equity of -- beat Xtant Medical Holdings's return on equity of -26.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    OWLT
    Owlet
    53.67% $0.11 $1.9M
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
  • What do Analysts Say About OWLT or XTNT?

    Owlet has a consensus price target of $10.83, signalling upside risk potential of 56.78%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 181.13%. Given that Xtant Medical Holdings has higher upside potential than Owlet, analysts believe Xtant Medical Holdings is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    OWLT
    Owlet
    3 0 0
    XTNT
    Xtant Medical Holdings
    2 0 0
  • Is OWLT or XTNT More Risky?

    Owlet has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.181, suggesting its less volatile than the S&P 500 by 118.091%.

  • Which is a Better Dividend Stock OWLT or XTNT?

    Owlet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Owlet pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OWLT or XTNT?

    Owlet quarterly revenues are $21.1M, which are smaller than Xtant Medical Holdings quarterly revenues of $32.9M. Owlet's net income of $3M is higher than Xtant Medical Holdings's net income of $58K. Notably, Owlet's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Owlet is 1.03x versus 0.70x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OWLT
    Owlet
    1.03x -- $21.1M $3M
    XTNT
    Xtant Medical Holdings
    0.70x -- $32.9M $58K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
47
RGC alert for Jun 18

Regencell Bioscience Holdings [RGC] is down 27.05% over the past day.

Sell
20
ENPH alert for Jun 18

Enphase Energy [ENPH] is up 4.1% over the past day.

Sell
26
FSLR alert for Jun 18

First Solar [FSLR] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock